Results 11 to 20 of about 26,982 (252)
Salud Pública de México, 2018 Objective. To evaluate the effectiveness of a combined strategy of human papillomavirus virus (HPV) vaccination and high-risk HPV screening to reduce the occurrence of anogenital and oropharyngeal neoplasms among men who have sex with men, people with ...
Eduardo Lazcano-Ponce +13 more
doaj +1 more source
Advanced Oropharyngeal Cancer Can Be Easily Missed During Esophagogastroduodenoscopy
European Journal of Case Reports in Internal Medicine, 2017 The case of an elderly man with an advanced oropharyngeal cancer that was missed during esophagogastroduodenoscopy is described. He was referred for endoscopic resection of superficial esophageal squamous cell neoplasms.
Kenta Hamada +3 more
doaj +1 more source
Should male children be vaccinated against human papillomavirus?
Revista de la Facultad de Medicina, 2017 Human papillomavirus (HPV) is the main risk factor for the development of cervical cancer in women and other types of malignancies in men, including penile, oropharyngeal and perianal cancer.
Gerardo Sebastián Legua-Pérez +1 more
doaj +1 more source
Oral and oropharyngeal cancer: time from first symptoms to treatment initiation and associated factors [PDF]
Brazilian Oral Research, 2023 The aim of this study was to evaluate the time elapsed from first symptoms to the treatment of oral and oropharyngeal cancer (OOC) and to identify variables associated with treatment delay.
Adriana Aparecida Silva da COSTA +10 more
doaj +1 more source
Historical Perspective: How the Discovery of HPV Virus Led to the Utilization of a Robot
Frontiers in Oral Health, 2022 The treatment of oropharyngeal cancer has undergone many paradigms shifts in recent decades. First considered a surgical disease, improvements in radiotherapy led to its popularization in the 1990s. Subsequently, the discovery of the human papillomavirus
Grégoire B. Morand +4 more
doaj +1 more source
Multiple primary cancers in patients with oropharyngeal neoplasms.
Practica Oto-Rhino-Laryngologica, 1985 1967年から1982年までに大阪大学耳鼻咽喉科, 放射線科を受診した中咽頭癌患者212名のうち, 重複癌が24名にみられ, その24名の重複癌患者について検討し, 以下の結果を得た.1) 発生頻度は, 中咽頭癌患者全体の11%にみられ, すでに報告されている下咽頭と並び, 中咽頭も重複癌が多い.2) 年齢, 性差は, 中咽頭癌患者全体と比較し差がない.3) 第1癌と第2癌の発生間隔については, 1年以内の同時発生が25%にみられ, 8割が7年以内にみられた.4) 部位の組合せでは, 喉頭が8例, 食道5例, 胃4例, 以下, 下咽頭, 舌がつづき, 呼吸器, 上部消化器との組合せが多い. また, 中咽頭の発癌の亜部位は, 軟口蓋9名, 扁桃7例と多かったが, 中咽頭癌はもともと扁桃に最も多いので,
Maeda, Hajime +3 more
openaire +2 more sources
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
BMC Cancer, 2022 Background The objective of our study was to investigate changes over the past decade in patient age and the prevalence of HPV in the population of patients with oropharyngeal carcinoma (OPC) treated at our center.
Philippe Gorphe +6 more
doaj +1 more source
Algorithm of nutritive support in patients with oropharyngeal malignant neoplasms
Head and neck tumors (HNT), 2016 The article is devoted to the actual problem of ensuring a radical surgical treatment of patients with tumors of oropharyngeal zone. We analyzed initial nutritional status of patients and its dynamics at the stages of preparation and implementation of major surgery.
S. A. Kravtsov +2 more
openaire +3 more sources
Brazilian Journal of Oral Sciences, 2021 Diagnosis of oral and oropharyngeal cancer in advanced stages may be associated with social nature factors, access to health care, education, occupation, and behavioral/ cultural factors.
Rebeca Cardoso Pedra +6 more
doaj +1 more source
Hepatology, EarlyView., 2022 Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou +13 more
wiley +1 more source